| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prions | 12 | 2018 | 24 | 1.620 |
Why?
|
| Muscular Dystrophy, Facioscapulohumeral | 8 | 2023 | 39 | 1.090 |
Why?
|
| RNA-Binding Proteins | 5 | 2018 | 388 | 0.610 |
Why?
|
| Homeodomain Proteins | 6 | 2023 | 256 | 0.560 |
Why?
|
| Amyotrophic Lateral Sclerosis | 7 | 2022 | 477 | 0.560 |
Why?
|
| Saccharomyces cerevisiae | 11 | 2016 | 530 | 0.510 |
Why?
|
| Software | 6 | 2014 | 374 | 0.490 |
Why?
|
| Gene Expression Profiling | 9 | 2016 | 712 | 0.480 |
Why?
|
| Neurodegenerative Diseases | 3 | 2018 | 128 | 0.480 |
Why?
|
| Algorithms | 8 | 2014 | 1000 | 0.470 |
Why?
|
| Mutation | 8 | 2019 | 2466 | 0.420 |
Why?
|
| Amino Acids | 1 | 2014 | 139 | 0.420 |
Why?
|
| Saccharomyces cerevisiae Proteins | 8 | 2014 | 420 | 0.420 |
Why?
|
| Prion Diseases | 5 | 2013 | 10 | 0.420 |
Why?
|
| Models, Genetic | 4 | 2013 | 253 | 0.390 |
Why?
|
| Selection, Genetic | 2 | 2007 | 69 | 0.350 |
Why?
|
| Phenotype | 5 | 2013 | 1157 | 0.320 |
Why?
|
| Genes, Fungal | 4 | 2008 | 54 | 0.310 |
Why?
|
| Adaptation, Biological | 2 | 2007 | 15 | 0.300 |
Why?
|
| TATA-Binding Protein Associated Factors | 5 | 2018 | 17 | 0.290 |
Why?
|
| Computational Biology | 4 | 2011 | 332 | 0.270 |
Why?
|
| Frontotemporal Dementia | 2 | 2022 | 126 | 0.270 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 2 | 2019 | 10 | 0.270 |
Why?
|
| Sequence Analysis, Protein | 5 | 2014 | 32 | 0.260 |
Why?
|
| DNA-Binding Proteins | 7 | 2018 | 1136 | 0.260 |
Why?
|
| Gene Expression | 4 | 2019 | 807 | 0.260 |
Why?
|
| Muscle, Skeletal | 5 | 2016 | 678 | 0.250 |
Why?
|
| Animals | 30 | 2022 | 19752 | 0.250 |
Why?
|
| Myoblasts | 3 | 2022 | 63 | 0.250 |
Why?
|
| Evolution, Molecular | 1 | 2007 | 295 | 0.240 |
Why?
|
| Calmodulin-Binding Proteins | 3 | 2016 | 22 | 0.230 |
Why?
|
| Terminology as Topic | 2 | 2003 | 138 | 0.210 |
Why?
|
| Genes, Insect | 1 | 2003 | 89 | 0.210 |
Why?
|
| Saccharomycetales | 1 | 2003 | 17 | 0.210 |
Why?
|
| Models, Statistical | 2 | 2004 | 309 | 0.210 |
Why?
|
| Mice | 20 | 2022 | 10331 | 0.200 |
Why?
|
| Disease Models, Animal | 7 | 2022 | 2078 | 0.200 |
Why?
|
| RNA-Binding Protein FUS | 5 | 2016 | 50 | 0.200 |
Why?
|
| Motor Neurons | 3 | 2013 | 206 | 0.200 |
Why?
|
| Sequence Analysis, DNA | 1 | 2003 | 397 | 0.200 |
Why?
|
| RNA-Binding Protein EWS | 4 | 2018 | 8 | 0.190 |
Why?
|
| Documentation | 1 | 2003 | 129 | 0.190 |
Why?
|
| Facial Expression | 2 | 2012 | 16 | 0.190 |
Why?
|
| Behavior, Animal | 4 | 2012 | 218 | 0.180 |
Why?
|
| Artificial Intelligence | 2 | 2004 | 173 | 0.180 |
Why?
|
| Transcription Factors | 3 | 2009 | 1459 | 0.180 |
Why?
|
| Periodontal Diseases | 1 | 2020 | 15 | 0.180 |
Why?
|
| Proteome | 2 | 2013 | 142 | 0.170 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2022 | 137 | 0.170 |
Why?
|
| Saliva | 1 | 2020 | 96 | 0.170 |
Why?
|
| Pain Measurement | 2 | 2012 | 336 | 0.170 |
Why?
|
| Antigens, Ly | 1 | 2019 | 40 | 0.170 |
Why?
|
| Blood-Brain Barrier | 1 | 2019 | 81 | 0.160 |
Why?
|
| Connectin | 1 | 2019 | 10 | 0.160 |
Why?
|
| Hermanski-Pudlak Syndrome | 1 | 2019 | 7 | 0.160 |
Why?
|
| Lipid-Linked Proteins | 1 | 2019 | 4 | 0.160 |
Why?
|
| DNA End-Joining Repair | 1 | 2019 | 24 | 0.160 |
Why?
|
| Algal Proteins | 1 | 2019 | 16 | 0.160 |
Why?
|
| Biomarkers | 4 | 2023 | 1212 | 0.160 |
Why?
|
| CRISPR-Associated Proteins | 1 | 2019 | 31 | 0.160 |
Why?
|
| Humans | 27 | 2023 | 60093 | 0.150 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2019 | 77 | 0.150 |
Why?
|
| Chlamydomonas reinhardtii | 1 | 2019 | 86 | 0.150 |
Why?
|
| Green Fluorescent Proteins | 3 | 2019 | 354 | 0.150 |
Why?
|
| Transduction, Genetic | 1 | 2019 | 233 | 0.150 |
Why?
|
| Gene Deletion | 2 | 2011 | 297 | 0.150 |
Why?
|
| Huntington Disease | 2 | 2012 | 146 | 0.150 |
Why?
|
| Flagella | 1 | 2019 | 151 | 0.150 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2018 | 106 | 0.150 |
Why?
|
| Central Nervous System | 1 | 2019 | 193 | 0.140 |
Why?
|
| Heterografts | 2 | 2016 | 62 | 0.140 |
Why?
|
| Cilia | 1 | 2019 | 157 | 0.140 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2018 | 144 | 0.140 |
Why?
|
| Peptide Termination Factors | 3 | 2013 | 20 | 0.140 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 2 | 2016 | 10 | 0.140 |
Why?
|
| Gene Expression Regulation | 4 | 2013 | 1538 | 0.140 |
Why?
|
| Cells, Cultured | 6 | 2022 | 2101 | 0.140 |
Why?
|
| Prion Proteins | 1 | 2016 | 4 | 0.130 |
Why?
|
| Cell Membrane | 1 | 2019 | 492 | 0.130 |
Why?
|
| Protein Structure, Tertiary | 3 | 2013 | 665 | 0.130 |
Why?
|
| Morpholinos | 1 | 2016 | 50 | 0.130 |
Why?
|
| Feeding Behavior | 3 | 2012 | 314 | 0.120 |
Why?
|
| Proteomics | 4 | 2023 | 264 | 0.120 |
Why?
|
| Databases, Genetic | 3 | 2004 | 83 | 0.120 |
Why?
|
| Asparagine | 2 | 2011 | 24 | 0.110 |
Why?
|
| Analgesics | 2 | 2012 | 100 | 0.110 |
Why?
|
| Membrane Proteins | 1 | 2019 | 845 | 0.110 |
Why?
|
| Insomnia, Fatal Familial | 2 | 2013 | 2 | 0.110 |
Why?
|
| Glutamine | 2 | 2011 | 47 | 0.110 |
Why?
|
| Genetic Markers | 1 | 2014 | 122 | 0.110 |
Why?
|
| Genetic Vectors | 1 | 2019 | 820 | 0.110 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2013 | 29 | 0.110 |
Why?
|
| Mice, Transgenic | 5 | 2019 | 1226 | 0.110 |
Why?
|
| Gene Silencing | 1 | 2016 | 379 | 0.110 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2013 | 47 | 0.110 |
Why?
|
| HIV Infections | 1 | 2020 | 927 | 0.110 |
Why?
|
| Codon | 1 | 2013 | 49 | 0.110 |
Why?
|
| Dependovirus | 1 | 2019 | 659 | 0.110 |
Why?
|
| Myositis, Inclusion Body | 1 | 2013 | 1 | 0.110 |
Why?
|
| Osteitis Deformans | 1 | 2013 | 2 | 0.110 |
Why?
|
| Proteins | 3 | 2022 | 743 | 0.110 |
Why?
|
| Bronchi | 1 | 2013 | 79 | 0.110 |
Why?
|
| Cytoplasmic Granules | 1 | 2013 | 50 | 0.110 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2013 | 60 | 0.110 |
Why?
|
| Exome | 1 | 2013 | 73 | 0.100 |
Why?
|
| Telomere | 1 | 2013 | 48 | 0.100 |
Why?
|
| Drosophila melanogaster | 4 | 2018 | 480 | 0.100 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 351 | 0.100 |
Why?
|
| RNA, Messenger | 3 | 2013 | 1469 | 0.100 |
Why?
|
| Mutant Proteins | 1 | 2013 | 105 | 0.100 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2012 | 24 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2012 | 53 | 0.100 |
Why?
|
| alpha-Synuclein | 2 | 2010 | 22 | 0.100 |
Why?
|
| Frontotemporal Lobar Degeneration | 1 | 2012 | 10 | 0.100 |
Why?
|
| Hypothalamus | 1 | 2012 | 119 | 0.100 |
Why?
|
| Fungi | 1 | 2012 | 50 | 0.100 |
Why?
|
| Animals, Laboratory | 1 | 2012 | 6 | 0.100 |
Why?
|
| Genome | 2 | 2005 | 253 | 0.100 |
Why?
|
| Circadian Rhythm | 2 | 2012 | 371 | 0.100 |
Why?
|
| Amino Acid Sequence | 6 | 2013 | 1580 | 0.100 |
Why?
|
| Antifungal Agents | 1 | 2012 | 117 | 0.090 |
Why?
|
| Molecular Sequence Data | 6 | 2013 | 1973 | 0.090 |
Why?
|
| Laboratories | 1 | 2011 | 26 | 0.090 |
Why?
|
| Genotype | 4 | 2019 | 643 | 0.090 |
Why?
|
| Nuclear Proteins | 2 | 2013 | 760 | 0.090 |
Why?
|
| Trans-Activators | 1 | 2013 | 295 | 0.090 |
Why?
|
| Dietary Fats | 1 | 2012 | 204 | 0.090 |
Why?
|
| Activin Receptors, Type II | 1 | 2011 | 9 | 0.090 |
Why?
|
| Myostatin | 1 | 2011 | 13 | 0.090 |
Why?
|
| Species Specificity | 2 | 2019 | 334 | 0.090 |
Why?
|
| Multigene Family | 1 | 2011 | 93 | 0.090 |
Why?
|
| Pain, Postoperative | 1 | 2012 | 133 | 0.090 |
Why?
|
| Gene Knockout Techniques | 1 | 2011 | 88 | 0.090 |
Why?
|
| Female | 13 | 2023 | 31229 | 0.090 |
Why?
|
| Spinal Cord | 1 | 2011 | 197 | 0.090 |
Why?
|
| Internet | 1 | 2014 | 463 | 0.090 |
Why?
|
| Sequence Alignment | 3 | 2012 | 292 | 0.090 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 346 | 0.090 |
Why?
|
| Sex Characteristics | 1 | 2012 | 198 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 6 | 2013 | 3220 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 1 | 2011 | 161 | 0.090 |
Why?
|
| Gene Knock-In Techniques | 1 | 2009 | 34 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 677 | 0.080 |
Why?
|
| Decision Trees | 3 | 2004 | 52 | 0.080 |
Why?
|
| Genetic Therapy | 1 | 2016 | 744 | 0.080 |
Why?
|
| Asthma | 1 | 2013 | 423 | 0.080 |
Why?
|
| Genes, Reporter | 2 | 2019 | 243 | 0.080 |
Why?
|
| Male | 11 | 2020 | 27963 | 0.080 |
Why?
|
| Pain | 1 | 2011 | 403 | 0.080 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2007 | 42 | 0.070 |
Why?
|
| Gene Regulatory Networks | 1 | 2009 | 139 | 0.070 |
Why?
|
| Genome, Fungal | 2 | 2009 | 40 | 0.070 |
Why?
|
| Finite Element Analysis | 1 | 2007 | 14 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2007 | 98 | 0.070 |
Why?
|
| Models, Biological | 3 | 2009 | 1143 | 0.070 |
Why?
|
| Gene Expression Regulation, Fungal | 2 | 2005 | 123 | 0.070 |
Why?
|
| Databases, Protein | 2 | 2004 | 47 | 0.070 |
Why?
|
| Ecosystem | 1 | 2006 | 40 | 0.070 |
Why?
|
| Protein Domains | 2 | 2018 | 141 | 0.070 |
Why?
|
| Immunohistochemistry | 3 | 2013 | 854 | 0.070 |
Why?
|
| Pattern Recognition, Automated | 2 | 2004 | 61 | 0.060 |
Why?
|
| Mass Spectrometry | 2 | 2004 | 288 | 0.060 |
Why?
|
| Mice, Knockout | 4 | 2013 | 1998 | 0.060 |
Why?
|
| HeLa Cells | 2 | 2018 | 531 | 0.060 |
Why?
|
| Peptide Library | 1 | 2004 | 36 | 0.060 |
Why?
|
| Probability | 1 | 2004 | 173 | 0.060 |
Why?
|
| Hypermedia | 1 | 2003 | 2 | 0.050 |
Why?
|
| Cell Line | 2 | 2022 | 2018 | 0.050 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 209 | 0.050 |
Why?
|
| Genes, Homeobox | 1 | 2023 | 25 | 0.050 |
Why?
|
| Natural Language Processing | 1 | 2003 | 68 | 0.050 |
Why?
|
| Aging | 1 | 2008 | 731 | 0.050 |
Why?
|
| Placenta | 1 | 2023 | 60 | 0.050 |
Why?
|
| Apoptosis | 1 | 2007 | 1040 | 0.050 |
Why?
|
| User-Computer Interface | 1 | 2003 | 131 | 0.050 |
Why?
|
| Forecasting | 1 | 2003 | 221 | 0.050 |
Why?
|
| PAX3 Transcription Factor | 1 | 2022 | 13 | 0.050 |
Why?
|
| Dipeptides | 1 | 2022 | 61 | 0.050 |
Why?
|
| Phylogeny | 1 | 2003 | 334 | 0.050 |
Why?
|
| Young Adult | 3 | 2020 | 4394 | 0.050 |
Why?
|
| C9orf72 Protein | 1 | 2022 | 98 | 0.050 |
Why?
|
| Muscle Development | 1 | 2022 | 53 | 0.050 |
Why?
|
| Genomics | 1 | 2004 | 314 | 0.050 |
Why?
|
| Regeneration | 1 | 2022 | 92 | 0.050 |
Why?
|
| Video Recording | 2 | 2012 | 126 | 0.050 |
Why?
|
| Suprachiasmatic Nucleus | 2 | 2012 | 141 | 0.050 |
Why?
|
| Binding Sites | 1 | 2003 | 872 | 0.050 |
Why?
|
| Base Sequence | 1 | 2003 | 1307 | 0.050 |
Why?
|
| Mutation, Missense | 2 | 2012 | 180 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2020 | 2477 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2022 | 250 | 0.040 |
Why?
|
| Body Weight | 2 | 2012 | 381 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2020 | 121 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2022 | 267 | 0.040 |
Why?
|
| Metabolomics | 1 | 2020 | 53 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2020 | 136 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 2 | 2013 | 417 | 0.040 |
Why?
|
| Amyloid | 2 | 2011 | 63 | 0.040 |
Why?
|
| Quantitative Trait Loci | 1 | 2019 | 71 | 0.040 |
Why?
|
| Stress, Physiological | 2 | 2013 | 186 | 0.040 |
Why?
|
| Organisms, Genetically Modified | 1 | 2019 | 8 | 0.040 |
Why?
|
| Frameshift Mutation | 1 | 2019 | 29 | 0.040 |
Why?
|
| Oral Health | 1 | 2020 | 75 | 0.040 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2019 | 17 | 0.040 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2019 | 19 | 0.040 |
Why?
|
| Ellis-Van Creveld Syndrome | 1 | 2019 | 11 | 0.040 |
Why?
|
| Cerebellar Ataxia | 1 | 2019 | 13 | 0.040 |
Why?
|
| Axoneme | 1 | 2019 | 34 | 0.040 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2019 | 75 | 0.040 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2020 | 92 | 0.040 |
Why?
|
| Retinitis Pigmentosa | 1 | 2019 | 25 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2019 | 129 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2019 | 171 | 0.040 |
Why?
|
| Signal Transduction | 3 | 2019 | 2892 | 0.040 |
Why?
|
| Karyopherins | 1 | 2018 | 7 | 0.040 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2019 | 37 | 0.040 |
Why?
|
| beta Karyopherins | 1 | 2018 | 6 | 0.040 |
Why?
|
| Reproducibility of Results | 3 | 2011 | 1564 | 0.040 |
Why?
|
| Disease Progression | 2 | 2012 | 1054 | 0.040 |
Why?
|
| Alleles | 1 | 2019 | 423 | 0.040 |
Why?
|
| Bacteria | 1 | 2020 | 277 | 0.040 |
Why?
|
| Molecular Chaperones | 1 | 2018 | 99 | 0.040 |
Why?
|
| Protein Transport | 1 | 2019 | 398 | 0.040 |
Why?
|
| Gene Transfer Techniques | 1 | 2019 | 307 | 0.030 |
Why?
|
| Adult | 4 | 2018 | 15980 | 0.030 |
Why?
|
| Middle Aged | 4 | 2018 | 16540 | 0.030 |
Why?
|
| Child | 2 | 2020 | 4332 | 0.030 |
Why?
|
| Zebrafish | 1 | 2020 | 323 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2018 | 274 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2022 | 1297 | 0.030 |
Why?
|
| Ataxin-1 | 1 | 2016 | 4 | 0.030 |
Why?
|
| Heterogeneous Nuclear Ribonucleoprotein A1 | 1 | 2016 | 5 | 0.030 |
Why?
|
| Ataxin-2 | 1 | 2016 | 4 | 0.030 |
Why?
|
| Organelles | 1 | 2016 | 19 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2020 | 332 | 0.030 |
Why?
|
| Adolescent | 2 | 2020 | 5957 | 0.030 |
Why?
|
| Gene Targeting | 1 | 2016 | 82 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 582 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 193 | 0.030 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2016 | 86 | 0.030 |
Why?
|
| Homeostasis | 1 | 2018 | 343 | 0.030 |
Why?
|
| Pregnancy | 1 | 2023 | 2359 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 261 | 0.030 |
Why?
|
| Aged | 3 | 2018 | 13581 | 0.030 |
Why?
|
| Rats | 2 | 2011 | 1914 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2019 | 704 | 0.030 |
Why?
|
| Fungal Proteins | 2 | 2005 | 142 | 0.030 |
Why?
|
| Protein Interaction Mapping | 2 | 2004 | 71 | 0.030 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 2013 | 3 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2013 | 40 | 0.030 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2013 | 21 | 0.030 |
Why?
|
| Cell Size | 1 | 2013 | 41 | 0.030 |
Why?
|
| Ataxins | 1 | 2013 | 5 | 0.030 |
Why?
|
| Allergens | 1 | 2013 | 45 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 2501 | 0.030 |
Why?
|
| Ovalbumin | 1 | 2013 | 113 | 0.030 |
Why?
|
| Fluorescence | 1 | 2013 | 84 | 0.030 |
Why?
|
| Inclusion Bodies | 1 | 2013 | 14 | 0.030 |
Why?
|
| Transcriptome | 1 | 2016 | 337 | 0.030 |
Why?
|
| Immunization | 1 | 2013 | 129 | 0.030 |
Why?
|
| Dendrites | 1 | 2013 | 56 | 0.030 |
Why?
|
| Family Health | 1 | 2013 | 69 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2013 | 93 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2013 | 109 | 0.030 |
Why?
|
| Caloric Restriction | 1 | 2012 | 16 | 0.030 |
Why?
|
| Animal Feed | 1 | 2012 | 16 | 0.030 |
Why?
|
| Body Temperature | 1 | 2012 | 43 | 0.030 |
Why?
|
| Food Deprivation | 1 | 2012 | 12 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2014 | 516 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2013 | 161 | 0.030 |
Why?
|
| Behavior | 1 | 2012 | 37 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 391 | 0.020 |
Why?
|
| Genes, Regulator | 1 | 2012 | 27 | 0.020 |
Why?
|
| Candidiasis | 1 | 2012 | 40 | 0.020 |
Why?
|
| Candida | 1 | 2012 | 34 | 0.020 |
Why?
|
| Ketoprofen | 1 | 2012 | 2 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 594 | 0.020 |
Why?
|
| Drinking Behavior | 1 | 2012 | 9 | 0.020 |
Why?
|
| Host-Parasite Interactions | 1 | 2012 | 54 | 0.020 |
Why?
|
| Mycoses | 1 | 2012 | 41 | 0.020 |
Why?
|
| Carbazoles | 1 | 2012 | 13 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2013 | 365 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 193 | 0.020 |
Why?
|
| Computers | 1 | 2012 | 48 | 0.020 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2012 | 33 | 0.020 |
Why?
|
| Freund's Adjuvant | 1 | 2011 | 13 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2013 | 253 | 0.020 |
Why?
|
| Nociceptors | 1 | 2011 | 9 | 0.020 |
Why?
|
| Eating | 1 | 2012 | 139 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2012 | 133 | 0.020 |
Why?
|
| Light | 1 | 2012 | 201 | 0.020 |
Why?
|
| Acetaminophen | 1 | 2012 | 52 | 0.020 |
Why?
|
| Automation | 1 | 2011 | 58 | 0.020 |
Why?
|
| Environmental Exposure | 1 | 2013 | 212 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 291 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2012 | 281 | 0.020 |
Why?
|
| Morphine | 1 | 2011 | 52 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 118 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2004 | 1034 | 0.020 |
Why?
|
| Huntingtin Protein | 1 | 2012 | 138 | 0.020 |
Why?
|
| Quadriceps Muscle | 1 | 2011 | 15 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2011 | 179 | 0.020 |
Why?
|
| Temperature | 1 | 2012 | 298 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2011 | 59 | 0.020 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2011 | 37 | 0.020 |
Why?
|
| Muscular Diseases | 1 | 2011 | 47 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 805 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2012 | 366 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2010 | 75 | 0.020 |
Why?
|
| RNA | 1 | 2013 | 405 | 0.020 |
Why?
|
| tau Proteins | 1 | 2010 | 104 | 0.020 |
Why?
|
| Nitroso Compounds | 1 | 2009 | 3 | 0.020 |
Why?
|
| Ergosterol | 1 | 2009 | 3 | 0.020 |
Why?
|
| Mevalonic Acid | 1 | 2009 | 4 | 0.020 |
Why?
|
| Heat-Shock Response | 1 | 2009 | 35 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 1260 | 0.020 |
Why?
|
| Motor Activity | 1 | 2012 | 343 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2009 | 66 | 0.020 |
Why?
|
| Endopeptidase K | 1 | 2008 | 3 | 0.020 |
Why?
|
| Drosophila | 1 | 2012 | 420 | 0.020 |
Why?
|
| Heat Shock Transcription Factors | 1 | 2008 | 12 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 252 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2010 | 195 | 0.020 |
Why?
|
| Research Design | 1 | 2012 | 569 | 0.020 |
Why?
|
| Buprenorphine | 1 | 2012 | 189 | 0.020 |
Why?
|
| Cytosol | 1 | 2009 | 170 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2007 | 84 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2008 | 74 | 0.020 |
Why?
|
| Age Factors | 1 | 2012 | 1526 | 0.020 |
Why?
|
| Transfection | 1 | 2009 | 676 | 0.020 |
Why?
|
| Extinction, Biological | 1 | 2006 | 6 | 0.020 |
Why?
|
| Population Density | 1 | 2006 | 12 | 0.020 |
Why?
|
| Inflammation | 1 | 2013 | 1111 | 0.020 |
Why?
|
| Peptides | 1 | 2010 | 550 | 0.020 |
Why?
|
| Survival Rate | 1 | 2008 | 793 | 0.020 |
Why?
|
| Systems Integration | 1 | 2005 | 27 | 0.020 |
Why?
|
| Brain | 1 | 2013 | 1493 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2005 | 153 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2009 | 847 | 0.010 |
Why?
|
| Neurons | 1 | 2010 | 863 | 0.010 |
Why?
|
| Time Factors | 1 | 2012 | 3619 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2004 | 65 | 0.010 |
Why?
|
| RNA, Fungal | 1 | 2004 | 36 | 0.010 |
Why?
|
| Database Management Systems | 1 | 2003 | 20 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 2004 | 73 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2004 | 160 | 0.010 |
Why?
|
| Information Storage and Retrieval | 1 | 2003 | 80 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 5192 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 1100 | 0.010 |
Why?
|